化学名称: (5S,6R,7R,9R,16S)-16-hydroxy-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-14-one
微笑: C[C@](O[C@@]1([H])N(C2=CC=CC=C32)C4=C3C(C5=O)=C6[C@@H](N5)O)([C@@H]([C@H](NC)C1)OC)N7C4=C6C8=CC=CC=C78
印地语: InChI=1/C29H37Cl4N5O/c30-23-3-1-5-25(27(23)32)36-15-13-35(14-16-36)12-11-21-7-9-22(10-8-21)34-29(39)38-19-17-37(18-20-38)26-6-2-4-24(31)28(26)33/h1-6,21-22H,7-20H2,(H,34,39)/t21-,22-
Impurity profiling and stability-indicating method development and validation for the estimation of assay and degradation impurities of midostaurin in softgel capsules using HPLC and LC-MS
By Lakka, Narasimha Swamy; Kuppan, Chandrasekar; Ravinathan, Poornima
From Biomedical Chromatography (2021), Ahead of Print.
RP-HPLC method development and validation for the estimation of midostaurin in bulk and pharmaceutical dosage form
By Harikrishnan, Narayanaswamy; Subramanian, Gejalakshmi; Hemalatha, C. N.; Pavankumar, V.
From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2020), 11(4), 5108-5112
Impurity profiling and stability-indicating method development and validation for the estimation of assay and degradation impurities of midostaurin in softgel capsules using HPLC and LC-MS
By Lakka Narasimha Swamy; Kuppan Chandrasekar; Ravinathan Poornima
From Biomedical chromatography : BMC (2021), e5222